Document Detail


Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils.
MedLine Citation:
PMID:  3030903     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The metabolism of endogenous arachidonic acid P(AA) was investigated in activated neutrophils from 20 patients with Crohn's disease, 20 with ulcerative colitis, and 25 healthy volunteers. 1-14C-P(AA) was incorporated into intracellular pools of phospholipids prior to activation of the cells with ionophore A23187 and analyses of released arachidonic acid metabolites by thin layer chromatography. Total release of radioactivity expressing the release of arachidonic acid and its metabolites, was equal in the experimental and control groups, which suggests a normal substrate availability. In contrast, there was a marked increase in the relative release of leucotriene B4 (LTB4) and its omega-oxidation products, 20-hydroxy-LTB4 (20-OH-LTB4) and 20-carboxy-LTB4 (20-COOH-LTB4), with LTB4 values exceeding the reference interval in seven of 20 patients with Crohn's disease, median 8.7%, and in six of 20 patients with ulcerative colitis, median 7.7%, as compared with a median of 5.3% in healthy volunteers. Furthermore, a decreased release of unmetabolised arachidonic acid, correlating inversely with the release of LTB4 in all experimental and control groups, and normal values for the production of other metabolites of arachidonic acid--for example, 5-hydroxyeicosatetraenoic acid (5-HETE) and 12-hydroxyheptadecatrienoic acid (HHT), point to an enzymatic abnormality such as increased activity of leucotriene B synthetase. An increased capacity for release of LTB4, the major pro-inflammatory metabolite of arachidonic acid lipoxygenation by polymorphonuclear leucocytes, may contribute to perpetuation of the inflammation and to tissue destruction in chronic inflammatory bowel disease. Our findings agree with previous reports of an increased release of LTB4 by the colonic mucosa in this condition.
Authors:
O H Nielsen; I Ahnfelt-Rønne; J Elmgreen
Related Documents :
9250613 - Accumulation of arachidonic acid in ischemic/reperfused cardiac tissue: possible causes...
2515503 - An in vitro study of the effect of lipoxygenase and cyclo-oxygenase inhibitors of arach...
7250893 - Acute hepatic ischaemia in the pig- the changes in plasma hormones, amino acids and bra...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Gut     Volume:  28     ISSN:  0017-5749     ISO Abbreviation:  Gut     Publication Date:  1987 Feb 
Date Detail:
Created Date:  1987-05-11     Completed Date:  1987-05-11     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  181-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Arachidonic Acid
Arachidonic Acids / blood*
Calcimycin / pharmacology
Colitis, Ulcerative / blood*
Crohn Disease / blood*
Female
Humans
Leukotriene B4 / analogs & derivatives,  blood*
Male
Middle Aged
Neutrophils / drug effects,  metabolism*
Chemical
Reg. No./Substance:
0/Arachidonic Acids; 506-32-1/Arachidonic Acid; 52665-69-7/Calcimycin; 71160-24-2/Leukotriene B4; 79008-24-5/5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid; 83861-61-4/20-carboxy-leukotriene B4
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the...
Next Document:  Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.